May 2015

Prevention of Type 2 Diabetes Requires BOTH Intensive Lifestyle Interventions and Population-Wide Approaches

May 18, 2015

Evidence-Based Diabetes Management

The CDC's director of the Division of Diabetes Translation discusses the scientific evidence that supports the need for both lifestyle interventions and population-level efforts to combat type 2 diabetes in the United States.

At Joslin, We're Ready to Welcome the ADA to Boston

May 19, 2015

Evidence-Based Diabetes Management

The editor in chief of Evidence-Based Diabetes Management welcomes those coming to the ADA Scientific Sessions to attend sessions featuring faculty from Joslin Diabetes Center.

Preventing Ketoacidosis Complications in Diabetes

May 19, 2015

Evidence-Based Diabetes Management

Risk factors associated with diabetic ketoacidosis typically do not change. Preventing DKA should focus on identification of those most at risk and educating them good self-care to avoid incidents.

Toujeo and Afrezza: New and Improved Insulins, Limited by FDA Labeling Constraints

May 19, 2015

Evidence-Based Diabetes Management

Two new insulins marketed by Sanofi offer improved options for patients: Toujeo is longer acting than its predecessor, Lantus. Afrezza, an inhaled insulin, is gaining praise from patients, if not from Wall Street.

Focusing on Prediabetes Is the Key to Reversing the Rise in Diabetes

May 21, 2015

Evidence-Based Diabetes Management

Evidence-Based Diabetes Management invited the YMCA's Jonathan Lever, vice president for health strategy and innovation, to comment on his organization's involvement with the National Diabetes Prevention Program.